SARAH MOLITORIS: Open Payments
NPI 1548809023 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 23 payments from 11 companies in 2025. Trend: 2023 $764 · 2024 $413 · 2025 $673
Food & beverage: $588Education: $85
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $144 |
| ABBVIE INC. | 4 | $110 |
| PFIZER INC. | 5 | $99 |
| Astellas Pharma US Inc | 1 | $85 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| BIOPROTECT MEDICAL, INC. | 1 | $33 |
| IMMUNITYBIO, INC. | 2 | $32 |
| Endo USA, Inc. | 1 | $29 |
| TOLMAR, INC. | 1 | $22 |
| Calyxo, Inc. | 1 | $21 |
Products named: AMS 700, BOTOX, XTANDI, GEMTESA, BIOPROTECT BALLOON IMPLANT SYSTEM, ANKTIVA, XIAFLEX, JATENZO.
Industry payments across PA — which companies pay providers there.
